407
Participants
Start Date
October 1, 2021
Primary Completion Date
July 24, 2023
Study Completion Date
September 8, 2023
semaglutide 2.4 mg
semaglutide subcutaneous (s.c.) 2.4 mg once-weekly or semaglutide placebo once-weekly as adjunct to a reduced-calorie diet and increased physical activity
semaglutide 2.4 mg (placebo)
semaglutide subcutanous (s.c.) 2.4 mg once-weekly or semaglutide placebo once-weekly as adjunct to a reduced-calorie diet and increased physical activity
Dr Wilhase's rooms, Boksburg
Akershus Universitetssykehus, Nordbyhagen
Frederiksberg Hospital - Parker Institutet (Artrose), Frederiksberg
Senter for sykelig overvekt i Helse Sør-Øst, Tønsberg
Maxwell Centre, Durban
Dr J Reddy, Durban
Phoenix Pharma, Port Elizabeth
Klinik for Led og bindevævssygdomme, Aarhus N
King Khaled University Hospital,King Saud Univ. Med. City, Riyadh
King Faisal Specialist Hospital & Research Centre, Riyadh, Riyadh
Southgate Medical Group, LLP, West Seneca
Great Lakes Medical Research, Westfield
Complejo Hospitalario Universitario A Coruña, A Coruña
King Fahad Medical City, Riyadh
Health Res of Hampton Roads, Newport News
Hospital Clinico San Carlos, Madrid
Accellacare, Wilmington
Coastal Carolina Res Ctr., North Charleston
Centre Hospitalier Universitaire de Toulouse-Hopital Rangueil-2, Toulouse
Westside Center For Clinical Research, Jacksonville
Renstar Medical Research, Ocala
Baptist Health System, Montgomery
King Abdulaziz Hospital-Al Ahsa-National Guard, Al Ahsa
L-MARC Research Center, Louisville
Clínica Nuevas Tecnologías en Diabetes y Endocrinología, Seville
Cleveland Clinic_Cleveland, Cleveland
Prestige Clinical Research, Franklin
Arcturus Healthcare, PLC., Troy
Clinical Invest Special_Gurnee, Gurnee
Evanston Premier Hlthcr Res, Skokie
Centre Hospitalier de Clermont-Ferrand-Hopital Gabriel Montpied, Clermont-Ferrand
Sundance Clinical Research LLC, St Louis
Hospices Civils de Lyon-Hopital Lyon Sud-1, Pierre-Bénite
Aphp-Hopital La Pitie Salpetriere-3, Paris
CHU Pitié-Salpétrière, Paris
Ap-Hp-Hopital Europeen Georges Pompidou, Paris
Hôpital Européen Georges Pompidou, Paris
PrimeCare Medical Group, Houston
Centro de investigación médico asistencial S.A.S, Barranquilla
Desert Oasis Hlthcr Med Group, Palm Springs
Diablo Clinical Research, Inc., Walnut Creek
East West Medical Research Institute, Honolulu
CentrodeInvestigaciónenReumatologíayEspecialidadesMédicas, Bogotá
National Medical Research Center of Endocrinology, Moscow
Setchenov First Moscow State Medical University, Moscow
Federal Bureau for Medical and Social Expertise, Moscow
"SBCI HC Yaroslavl region Central City Hospital", Yaroslavl
Consultative & Diagnostic Center with a Outpatient Hospital, Saint Petersburg
Preventive Care S.A.S, Chía
Voronezh Regional Clinical Consultive-diagnostic Centre, Voronezh
"SIH Saratov Regional Clinical Hospital for War Veterans", Saratov
"PIH Clin Hosp RZD-Medicina former Kazan OJSC Rus Railways", Kazan'
Siberian State Medical University, Tomsk
"LLC Medical center Maksimum Zdorovia", Kemerovo
Ocean West Research Clinic, Surrey
Wharton Med Clin Trials, Hamilton
Premier Clinical Trial Research Network (PCTRN), Hamilton
Milestone Research, London
Dr. Anil K Gupta Medicine Professional Corporation, Toronto
Centre Medical Acadie, Montreal
Oslo us HF, Aker sykehus, Oslo
Botho ke Bontle Health Services, Pretoria
Forskningsmottagning Internmedicin (tidigare KFE), Malmo
Medicinkliniken Överviktsenheten USÖ, Örebro
S:t Göran Sjukhus, Stockholm
Department of Metabolism and Endocrinology, Stockholm
Lead Sponsor
Novo Nordisk A/S
INDUSTRY